# Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria

> **NCT00351273** · PHASE3 · COMPLETED · sponsor: **University of South Florida** · enrollment: 42 (actual)

## Conditions studied

- Arthritis, Reactive
- Reiter Disease

## Interventions

- **DRUG:** Doxycycline and Rifampin
- **DRUG:** Azithromycin and Rifampin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00351273
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2018-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351273, "Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00351273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*